PharmaTher Seeks FDA Orphan Drug Designation for GAMT Deficiency Treatment
PharmaTher submitted a request to the FDA for orphan drug designation for its GAMT deficiency treatment.
Related stories
Meta Loses Appeals Against Interim Measures Imposed by French Regulators
Meta lost its appeals against interim measures imposed by French regulators.
L impact | REGULATION | Oct 29, 2026, 10:27 AM UTC
Meta Loses Appeal Against French Regulatory Injunction
Meta Platforms lost its appeal against an injunction imposed by French regulators, Reuters reported.
M impact | REGULATION | Oct 29, 2026, 10:27 AM UTC
Meta loses appeal over French regulator's interim order
Meta Platforms lost its appeal against an interim measure ordered by France's regulator.
M impact | REGULATION | Oct 29, 2026, 10:27 AM UTC
Police raid Daewoong Pharmaceutical in alleged rebate probe
South Korean police searched Daewoong Pharmaceutical as part of an investigation into alleged rebates.
M impact | REGULATION | Oct 29, 2026, 10:24 AM UTC
Meta Loses Appeals Over French Media Publishing Rights Measures
Meta Platforms lost its appeals against interim measures imposed by French regulators over media organisations’ publishing rights, the Paris Court of Appeals said Thursday.
L impact | REGULATION | Oct 29, 2026, 10:23 AM UTC
HTX Agrees to Stop Unlawful Crypto Promotions in UK
The UK Financial Conduct Authority said it secured a High Court agreement requiring crypto exchange HTX not to knowingly promote cryptoasset services unlawfully to UK customers.
M impact | REGULATION | Oct 29, 2026, 10:23 AM UTC